MSDS506
SECTION 1: IDENTIFICATION
MSDS ID: MSDS506
PRODUCT NAME: PRESTONE(R) LOW TOX ANTIFREEZE/COOLANT
PRODUCT NUMBER: 70052, AF555, AF559
FORMULA NUMBER: YA-2792PG
MANUFACTURER: Honeywell Consumer Products Group
39 Old Ridgebury Road
Danbury, CT 06810-5109
CANADIAN OFFICE: Honeywell Consumer Products Group
3333 Unity Drive
Mississauga, Ontario L5L 3S6
INFORMATION PHONE NUMBER: (800)862-7737 (in the US)
(800)668-9349 (in Canada)
EMERGENCY PHONE NUMBER: CHEMTREC 1-800-424-9300 (in the US)
CANUTEC (613)996-6666 (in Canada)
MSDS DATE OF PREPARATION/REVISION: 08/20/04
PRODUCT USE: Antifreeze for automobile - consumer product
NFPA RATING (NFPA 704) - FIRE: 1
HEALTH: 1
REACTIVITY: 0
SECTION 2: PRODUCT COMPONENTS
HAZARDOUS COMPONENTS CAS# PERCENT EXPOSURE LIMITS
Propylene Glycol 57-55-6 90-100 50 ppm AIHA WEEL
Sodium Nitrite 7632-00-0 <0.5 None Established
OSHA PEL, ACGIH TLV
NON-HAZARDOUS INGREDIENTS >1%
Water 7732-18-5
SECTION 3: HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Green liquid with a characteristic odor. Not classified as
flammable or combustible but will burn under fire conditions. Direct
eye contact may cause transient discomfort. Swallowing large amounts
may cause nausea, vomiting, diarrhea, cyanosis, lowering of blood
pressure, rapid heartbeat and severe headache. Prolonged or repeated
skin contact may cause dermatitis or skin sensitization.
1
MSDS506
POTENTIAL HEALTH EFFECTS:
ACUTE HAZARDS
INHALATION: Mists my cause upper respiratory irritation with coughing.
SKIN CONTACT: Prolonged or repeated contact may cause dermatitis or skin
sensitization.
SKIN ABSORPTION: No adverse effects are expected due to the very low
systemic toxicity of propylene glycol.
EYE CONTACT: Direct contact may cause stinging and tearing but no
residual injury or discomfort.
INGESTION: Swallowing may cause gastrointestinal irritation, nausea,
vomiting or diarrhea. Lactic acidosis, stupor and seizures have been
reported following chronic ingestion of propylene glycol and in
individuals
overexposure to propylene glycol that have underlying kidney disease.
This product contains less than 0.5% sodium nitrite. Swallowing sodium
nitrite causes the formation of methemoglobin in the blood which may
result in cyanosis, lowering of blood pressure, rapid heartbeat and
severe headache. Doses as low as 14 mg/kg have been reported to cause
toxic effects.
CHRONIC HAZARDS: Repeated excessive ingestions may cause central nervous
system effects. Prolonged or repeated skin contact may cause
skin sensitization and an associated dermatitis in some individuals.
See section 11 for additional information.
MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: None currently known.
CARCINOGEN: None of the components of this product are listed as a
carcinogen or suspected carcinogen by IARC, NTP or OSHA.
SECTION 4: FIRST AID MEASURES
INHALATION: No adverse effects are expected, however, if irritation or
other symptoms develop, remove to fresh air. Seek medical attention if
symptoms persist.
SKIN CONTACT: Remove contaminated clothing and wash skin with soap and
water. Seek medical attention if irritation develops.
EYE CONTACT: Immediately flush with water, holding open eyelids, for
15 minutes. Seek medical attention if irritation persists.
INGESTION: If swallowed, get immediate medical advice by calling a
poison control center or emergency department. If advice is not
available and a significant quantity has been swallowed, give 1 glass
2
MSDS506
of water or milk and induce vomiting. Take the victim and the
product container to the nearest emergency treatment center or
hospital. Do not attempt to induce vomiting or give anything by mouth
to an unconscious person.
NOTES TO PHYSICIAN: Following acute ingestion signs of toxicity are
unlikely. Ethanol treatment as in ethylene glycol poisoning is
inappropriate. There is no specific antidote. Treatment should be
directed at the control of symptoms and the clinical condition.
Monitor for acidosis and central nervous system effects.
The principal toxic effects of sodium nitrite poisoning are vasodilation
and/or methemoglobinemia. Hypotension with syncope and tachycardia are
common findings. Coronary vasospasm due to acute withdrawal may be
seen. Paradoxical bradycardia may occur rarely. Coronary ischemia and
cerebrovascular disease can occur due to severe hypotension. Immediate
life support measures should be provided because of associated
hypotension,
seizures, and methemoglobinemia-induced anoxia. Immediately contact a
poison center or hospital emergency department for treatment advice.
SECTION 5: FIRE AND EXPLOSION DATA
FLASH POINT: 230 F (110 C) TOC
AUTOIGNITION TEMPERATURE: Not determined
NFPA CLASSIFICATION: IIIB
FLAMMABILITY LIMITS: LEL: 2.6% (propylene glycol)
UEL: 12.5% (propylene glycol)
EXTINGUISHING MEDIA: Use water fog, carbon dioxide, alcohol resistant
foam or dry chemical. Do not use direct water stream.
SPECIAL FIRE FIGHTING PROCEDURES: Firefighters should wear positive
pressure self-contained breathing apparatus and full protective
clothing for fires in areas where chemicals are used or stored. Cool fire
exposed containers with water spray or fog.
UNUSUAL FIRE HAZARDS: A solid stream of water directed into
hot, burning liquid can cause frothing. Heat from fire may generate
flammable vapor. Fine sprays or mists may be combustible at
temperatures below the normal flash point.
HAZARDOUS COMBUSTION PRODUCTS: Burning may produce carbon monoxide,
carbon dioxide and aldehydes.
SECTION 6: ACCIDENTAL RELEASE MEASURES
Wear appropriate protective clothing and equipment (See Section 8).
3
MSDS506
Collect with absorbent material and place in appropriate, labeled
container for disposal or, if permitted flush spill area with water.
SECTION 7: HANDLING AND STORAGE
Avoid eye and prolonged or repeated skin contact.
Avoid breathing vapors or mists.
Wash exposed skin thoroughly with soap and water after use.
Keep container away from open flames and excessive heat.
Do not reuse empty containers unless properly cleaned.
Empty containers retain product residue and may be dangerous. Do not
cut, weld, drill, etc. containers, even empty.
Sudden release of hot organic chemical vapors or mists from process
equipment operating at elevated temperature and pressure, or sudden
ingress of air into vacuum equipment, may result in ignitions without
any obvious ignition sources. Published "autoignition" or "ignition"
temperatures cannot be treated as safe operating temperatures in
chemical processes without analysis of the actual process conditions.
Use of this product in elevated temperature applications should be
thoroughly evaluated to assure safe operating conditions.
SECTION 8: EXPOSURE CONTROLS/PERSONAL PROTECTION
VENTILATION: Use general ventilation or local exhaust as required to
minimize exposures.
RESPIRATORY PROTECTION: None normally needed.
GLOVES: None normally needed. For prolonged contact nitrile gloves
can be worn.
EYE PROTECTION: Safety glasses or goggles recommended if splashing is
possible.
OTHER PROTECTIVE EQUIPMENT/CLOTHING: Appropriate protective clothing
as needed to minimize skin contact.
SECTION 9: PHYSICAL AND CHEMICAL PROPERTIES
APPEARANCE AND ODOR: Green liquid with a characteristic odor.
There is no odor threshold data for this product.
pH: 10.6 SPECIFIC GRAVITY: 1.03
BOILING POINT (F): 307 F VAPOR PRESSURE: Less than 0.1 mmHg @
68 F
MELTING POINT (F): Not determined VAPOR DENSITY: 2.6
SOLUBILITY IN WATER: Complete EVAPORATION RATE: Not determined
PERCENT VOLATILE: None VISCOSITY: Not determined
COEFFICIENT OF WATER/OIL DISTRIBUTION: Not determined
4
MSDS506
SECTION 10: STABILITY AND REACTIVITY
STABILITY: Stable
CONDITIONS TO AVOID: None
INCOMPATIBILITY: Strong oxidizing agents and reducing agents.
DECOMPOSITION PRODUCTS: Carbon monoxide, carbon dioxide and aldehydes.
HAZARDOUS POLYMERIZATION: Will not occur.
CONDITIONS TO AVOID: None known.
SECTION 11: TOXICOLOGICAL INFORMATION
Propylene Glycol: LD50 Oral Rat: 20 gm/kg
LD50 Skin Rabbit: 20.8 gm/kg
Sodium Nitrite: LD50 Oral Rat: 180 mg/kg
LC50 Inhalation Rat: 5.5 mg/m3/4 hr.
This product contains less than 0.2% tolyltriazole which has demonstrated
mutagenic activity in a bacterial test system. A correlation has been
established between mutagenic activity and carcinogenic activity for many
chemicals. Tolyltriazole has not been identified as a carcinogen or
probable
carcinogen by NTP, IARC or OSHA.
SECTION 12: ECOLOGICAL INFORMATION
No ecotoxicity data is currently available.
SECTION 13: DISPOSAL INFORMATION
Dispose of product in accordance with all local, state/provincial and
federal regulations.
SECTION 14: TRANSPORT INFORMATION
U.S. DOT HAZARD CLASSIFICATION: Not Regulated
DOT MARINE POLLUTANTS: This product does not contain Marine
Pollutants as defined in 49 CFR 171.8.
IMDG CODE SHIPPING CLASSIFICATION: Not Regulated
SECTION 15: REGULATORY INFORMATION
EPA SARA 311/312 HAZARD CLASSIFICATION: Not hazardous
EPA SARA 313: This Product Contains the Following Chemicals
Subject to Annual Release Reporting Requirements Under SARA Title
III, Section 313 (40 CFR 372): None
5
MSDS506
PROTECTION OF STRATOSPHERIC OZONE: This product is not known to
contain or to have been manufactured with ozone depleting
substances as defined in 40 CFR Part 82, Appendix A to Subpart A.
CERCLA SECTION 103: This product is not subject to CERCLA reporting
requirements, however, many states have more stringent release
reporting requirements. Report spills required under federal, state
and local regulations.
CALIFORNIA PROPOSITION 65: This product does not contain substances
known to the State of California to cause Cancer and/or Reproductive
Harm.
EPA TSCA INVENTORY: All of the components of this material are listed
on the Toxic Substances Control Act (TSCA) Chemical Substances
Inventory.
CANADIAN WHMIS CLASSIFICATION: Not a controlled product.
CANADIAN WHMIS HAZARD SYMBOLS: Not applicable
This MSDS has been prepared according to the criteria of the Controlled
Products Regulation (CPR) and the MSDS contains all of the information
required by the CPR.
EUROPEAN INVENTORY OF EXISTING COMMERCIAL CHEMICAL SUBSTANCES
(EINECS): All of the ingredients are listed on the EINECS inventory.
SECTION 16: OTHER INFORMATION
Revision Summary: Section 5: NFPA Classification
This MSDS is directed to professional users and bulk handlers of the
product. Consumer products are labeled in accordance with Federal
Hazardous Substances Act regulations.
While Prestone Products Corporation believes that the data contained
herein are factual and the opinions expressed are those of qualified
experts regarding the results of tests conducted, the data are not to
be taken as a warranty or representation for which Prestone Products
Corporation assumes legal responsibility. They are offered for your
consideration, investigation and verification. Any use of these data
and information must be determined by the user to be in accordance
with applicable federal, state and local laws and regulations.
If more information is needed, please contact:
Technical Services
Prestone Products Corporation
55 Federal Road
Danbury, CT 06810-5109
(800)-862-7737
6
MSDS506
7
|